Careers  |  Sign In  |  Register

Latest in Hematology-Oncology

Reuters Health • The Doctor's Channel Daily Newscast

Rosuvastatin reduces risk of venous thromboembolism in healthy adults

ORLANDO (Reuters Health) - New findings, announced here during the annual meeting of the American College of Cardiology, show that rosuvastatin significantly reduces the risk of venous thromboembolism (VTE) in apparently healthy adults. Results from the JUPITER (Justification for the Use of Statins in...

Reuters Health • The Doctor's Channel Daily Newscast

High cut-off dialysis useful for myeloma-related renal failure

NEW YORK (Reuters Health) – Use of a high cut-off dialyzer can help patients with acute renal failure secondary to multiple myeloma become dialysis free, the results of a small study suggest. "This study saw over 70% of patients becoming independent of dialysis, which is greatly above the rate expected...

Reuters Health • The Doctor's Channel Daily Newscast

Thalidomide improves myeloma survival after stem cell transplantation

NEW YORK (Reuters Health) – Consolidation therapy with low-dose thalidomide and prednisolone can improve survival in patients with multiple myeloma who have undergone autologous stem-cell transplantation (ASCT), according to a report in the March 9th issue of the Journal of Clinical Oncology. The...